CapVest Partners has agreed to purchase a majority stake in German generics manufacturer Stada Arzneimittel, marking one of the largest deals in the healthcare sector this year. Takeover company ...

Kevin A. Schulman ([email protected]) is a professor of medicine at Stanford University, in Stanford, California. He is a board member and shareholder of Grid Therapeutics (an early stage ...

NEW YORK--Some Chinese companies now racing to make generic versions of Novo Nordisk’s Wegovy also supplied ingredients for more than a billion makeshift doses of weight-loss drugs sold online in the ...

Citigroup recommends buying Divis Laboratories, citing reasonable valuations and sector tailwinds. JP Morgan maintains an underweight rating on Mazgaon Dockyard due to weak quarterly numbers and order ...

Since Zayne's 2024 birthday event was autumn themed (even though, as a September 5th baby, his birthday's not even really out of summer), the 2025 event takes the logical next step with a winter theme ...

Learn how to build an easy automatic bamboo farm in Minecraft 1.21+. This compact design works in both Java and Bedrock Edition and provides a steady supply of bamboo — perfect for fuel, scaffolding, ...

More than three years after launching a new corporate structure, Novartis is still making changes to its organization. In the latest move to streamline its business, Novartis will lay off 58 employees ...

Need more villagers for your survival world? In this tutorial, you’ll learn how to build an easy villager breeder farm in Minecraft 1.21+, fully working in both Java and Bedrock Edition. This design ...

Thomas Tuchel challenged England to "prove a point" against Serbia in next week's crucial World Cup qualifier after his side laboured to a 2-0 win over minnows Andorra on Saturday. Christian Garcia's ...

Melania Trump made rare public remarks to kick off a press conference for the White House Task Force on Artificial Intelligence Education on Thursday, grandly proclaiming the potential for AI ...

As the oral GLP-1 race intensifies, Eli Lilly has slimmed back the number of phase 2 trials it is conducting for one of its contenders. The Big Pharma had been running three midstage studies of the ...